SCHEMBL6521770

SCHEMBL6521770

Cc1n[nH]c2c1c(=O)n(CCNCc1ccccc1)c1ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.40
HDAC4 P56524 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC9 Q9UKV0 2/20 0.40
HDAC5 Q9UQL6 2/20 0.40
POLB P06746 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
HTR6 P50406 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
PLK1 P53350 1/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6518571 0.94 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6518514 0.84 MEN1 (0.43) LMNAHPGDPLK1MEN1KMT2A
SCHEMBL21067780 0.81 CYP1A2 (0.48) SMN1; SMN2LMNAALDH1A1HPGDPLK1
SCHEMBL6518602 0.80 AURKA (0.41) POLBLMNAALDH1A1HPGDPLK1
SCHEMBL6514910 0.80 CHEK1 (0.49) POLBLMNAALDH1A1HPGDPLK1
SCHEMBL6523698 0.78 TSHR (0.47) POLBLMNAALDH1A1HPGDAURKA
SCHEMBL6508661 0.78 TOP2A (0.53) SMN1; SMN2HTR6PLK1AURKAKDR
SCHEMBL6515436 0.78 CHEK1 (0.51) POLBLMNAALDH1A1HPGDPLK1
SCHEMBL6523226 0.78 FAAH (0.44) POLBSMN1; SMN2LMNAALDH1A1HPGD
Hydrochloric Acid SCHEMBL6518743 0.77 TOP2A (0.52) SMN1; SMN2HTR6AURKAKDRAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050245563-A1 Chk-1 inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245563-A1 Chk-1 inhibitors CHKA, CHKB, CHEK1 HDAC3 682/4885HDAC4 1043/4885HDAC1 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.